Cite
HARVARD Citation
Takeuchi, T. et al. (n.d.). SAT0173 Effects of denosumab, a subcutaneous rankl inhibitor, on the progression of structural damage in japanese patients with rheumatoid arthritis treated with csdmards: result from the long-term treatment of phase 3, desirable study. Annals of the rheumatic diseases. pp. 947-948. [Online].